WallStreetZenWallStreetZen

NASDAQ: OLMA
Olema Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for OLMA

Based on 4 analysts offering 12 month price targets for Olema Pharmaceuticals Inc.
Min Forecast
$20.00+102.02%
Avg Forecast
$22.50+127.27%
Max Forecast
$25.00+152.53%

Should I buy or sell OLMA stock?

Based on 4 analysts offering ratings for Olema Pharmaceuticals Inc.
Strong Buy
Strong Buy
2 analysts 50%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their OLMA stock forecasts and price targets.

OLMA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-02
lockedlocked$00.00+00.00%2024-03-12
lockedlocked$00.00+00.00%2024-03-12
lockedlocked$00.00+00.00%2024-01-30

1 of 1

Forecast return on equity

Is OLMA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.66%

Forecast return on assets

Is OLMA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

OLMA revenue forecast

What is OLMA's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$14.6M
Avg 2 year Forecast
$26.0M
Avg 3 year Forecast
$305.3M

OLMA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
OLMA$9.90$22.50+127.27%Strong Buy
PHAT$9.48$21.33+125.03%Buy
PRME$4.59$17.00+270.37%Strong Buy
PROK$2.40$2.50+4.17%Hold
VERV$6.66$37.50+463.06%Strong Buy

Olema Pharmaceuticals Stock Forecast FAQ

Is Olema Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: OLMA) stock is to Strong Buy OLMA stock.

Out of 4 analysts, 2 (50%) are recommending OLMA as a Strong Buy, 2 (50%) are recommending OLMA as a Buy, 0 (0%) are recommending OLMA as a Hold, 0 (0%) are recommending OLMA as a Sell, and 0 (0%) are recommending OLMA as a Strong Sell.

If you're new to stock investing, here's how to buy Olema Pharmaceuticals stock.

What is OLMA's revenue growth forecast for 2026-2028?

(NASDAQ: OLMA) Olema Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Olema Pharmaceuticals's revenue in 2024 is $0.On average, 2 Wall Street analysts forecast OLMA's revenue for 2026 to be $815,796,071, with the lowest OLMA revenue forecast at $373,510,470, and the highest OLMA revenue forecast at $1,258,081,673. On average, 2 Wall Street analysts forecast OLMA's revenue for 2027 to be $1,452,105,824, with the lowest OLMA revenue forecast at $1,235,715,776, and the highest OLMA revenue forecast at $1,668,495,871.

In 2028, OLMA is forecast to generate $17,072,727,443 in revenue, with the lowest revenue forecast at $3,919,623,344 and the highest revenue forecast at $30,225,831,542.

What is OLMA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: OLMA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is OLMA's Price Target?

According to 4 Wall Street analysts that have issued a 1 year OLMA price target, the average OLMA price target is $22.50, with the highest OLMA stock price forecast at $25.00 and the lowest OLMA stock price forecast at $20.00.

On average, Wall Street analysts predict that Olema Pharmaceuticals's share price could reach $22.50 by Apr 2, 2025. The average Olema Pharmaceuticals stock price prediction forecasts a potential upside of 127.27% from the current OLMA share price of $9.90.

What is OLMA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: OLMA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.